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Abstract: Curcumin (diferuloylmethane) is found in the rhizomes of the turmeric plant 
(Curcuma longa L.) and has been used for centuries as a dietary spice and as a traditional 
Indian medicine used to treat different conditions. At the cellular level, curcumin 
modulates important molecular targets: transcription factors, enzymes, cell cycle proteins, 
cytokines, receptors and cell surface adhesion molecules. Because many of the curcumin 
targets mentioned above participate in the regulation of bone remodeling, curcumin may 
affect the skeletal system. Nitric oxide (NO) is a gaseous molecule generated from  
L-arginine during the catalization of nitric oxide synthase (NOS), and it plays crucial roles 
in catalization and in the nervous, cardiovascular and immune systems. Human osteoblasts 
have been shown to express NOS isoforms, and the exact mechanism(s) by which NO 
regulates bone formation remain unclear. Curcumin has been widely described to inhibit 
inducible nitric oxide synthase expression and nitric oxide production, at least in part via 
direct interference in NF-κB activation. In the present study, after exposure of human 
osteoblast-like cells (MG-63), we have observed that curcumin abrogated inducible NOS 
expression and decreased NO levels, inhibiting also cell prolifieration. This effect was 
prevented by the NO donor sodium nitroprusside. Under osteogenic conditions, curcumin 
also decreased the level of mineralization. Our results indicate that NO plays a role in the 
osteoblastic profile of MG-63 cells. 
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1. Introduction 
Curcumin ((1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione or 
diferuloylmethane) is found in the rhizomes of the turmeric plant (Curcuma longa L.), a perennial herb 
belonging to the ginger family that is cultivated extensively in south and southeast tropical Asia [1]. 
Turmeric has been used for centuries as a dietary spice and as a traditional Indian medicine used to 
treat anorexia, rheumatism, sinusitis, hepatic disorders and inflammation [2]. It has also been 
recognized for its antiproliferative properties in cancer treatment [1]. In particular, curcumin has been 
shown to regulate the expression of genes implicated in cell proliferation, metastasis, chemotherapy 
resistance and angiogenesis [1,3]. The anti-neoplastic properties of curcumin have been exhibited in 
many types of malignancies, including breast cancer, colon cancer, kidney cancer, leukemia, prostate 
cancer, melanoma and osteosarcoma [1,4]. However, the potential of curcumin has not been 
systematically examined through multi-center, randomized, double-blind, placebo-controlled clinical 
trials [1]. 
At the cellular level, curcumin modulates important molecular targets: transcription factors (such as 
nuclear factor-κB, activating protein-1, β-catenin and peroxisome proliferator-activated receptor-γ), 
enzymes (cyclooxygenase-2,5-lipoxygenase and inducible nitric oxide synthase), cell cycle proteins 
(cyclin D1 and p21), cytokines (tumor necrosis factor-α, interleukin-1, interleukin-6 and chemokines), 
receptors (epidermal growth factor receptor, low-density lipoprotein receptor, estrogen receptor-α) and 
cell surface adhesion molecules [1,5–7]. Because many of the curcumin targets mentioned above 
participate in the regulation of bone remodeling, curcumin may affect the skeletal system. In fact, the 
effects of curcumin on osteoclasts (cells which resorb bone) and osteoblasts (cells responsible for bone 
formation) have previously been investigated in vitro [8–12] and in vivo [13–16]. 
Nitric oxide (NO) is a gaseous molecule generated from L-arginine during the catalization of nitric 
oxide synthase (NOS), and it plays crucial roles in catalization and in the nervous, cardiovascular and 
immune systems [17]. Three isoforms of NOS are recognized: neural NOS (nNOS or NOS-1), 
inducible NOS (iNOS or NOS-2) and endothelial NOS (eNOS or NOS-3) [18]. Human osteoblasts 
have been shown to express both iNOS and eNOS [19]. Several agonists, such as proinflammatory 
cytokines and bacterial lipopolysaccharides, increase iNOS expression, whereas eNOS activities are 
induced by stimulators, such as estradiol and estrogen, indicating that iNOS and eNOS may play a role 
in bone inflammation and physiology [19,20]. The exact mechanism(s) by which NO regulates bone 
formation remain unclear. It has been proposed that NO directly induces osteoblast proliferation [21], 
while others have demonstrated that NO stimulates osteoblast proliferation via the induction of 
prostaglandin E2 (PGE2) production [22]. Evidence from gene knock-out studies has shown that bone 
formation is, at least in part, mediated by nitric oxide (NO), because mice deficient in endothelial nitric 
oxide synthase (eNOS) and mice deficient in the eNOS downstream effector (cGMP)-dependent 
protein kinase (PKG) show bone abnormalities. Additionally, inducible NOS (iNOS)-null mice also 
show imbalances in bone osteogenesis and abnormalities in bone healing [23]. Curcumin has been 
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widely described to inhibit iNOS expression and NO production, at least in part via direct interference 
in NF-κB activation [24,25]. Therefore, the aim of the present study was to test the hypothesis that the 
exposure of human osteoblast-like cells to curcumin may affect growth and mineralization by a 
mechanism partially regulated by NO. 
2. Results and Discussion 
2.1. Cell Proliferation and NO Levels 
Cell proliferation was measured using the MTT assay (Figure 1a,b). Curcumin significantly 
decreased cell viability in a dose-dependent manner in MG-63 cells. A dose of 20 µM of curcumin 
decreased cell viability to below 80% after 24 h of culture and 30 µM of curcumin decreased viability 
to below 50% (p < 0.001). No significant differences were found after 10 µM curcumin exposure  
(p > 0.05) (Figure 1a). Thus, 10 µM curcumin was selected as the working concentration for the rest of 
the experiments. At the tested concentrations, L-NAME moderately affected cell viability (p < 0.05) 
(Figure 1b), while the combination of L-NAME and curcumin substantially decreased cell viability 
after 24 h of culture (p < 0.001 vs. control cells) (Figure 1b). Supplementation of MG-63 cultures with 
0.2 mM SNP prevented the cell death observed after co-stimulation with L-NAME and curcumin  
(p > 0.05 vs. control cells) (Figure 1b). 
Figure 1. (a) Concentration-dependent effect of curcumin on MG-63 cells viability. Cells 
were incubated with various concentrations of curcumin for 24 h, after which cell viability 
was measured using MTT. Bars represent mean values, error bars represent SEM: n.s.  
(no significant difference compared to control cells), ** significant difference compared to 
control cells (p < 0.001). (b) Effect of curcumin (10 µM); L-NG-Nitroarginine Methyl 
Ester (L-NAME) (1 mM) and Sodium nitroprusside (SNP) (0.2 mM) at the indicated 
combinations after 24 h of exposure. Bars represent mean values, n.s. (no significant 
difference compared to control cells), * significant difference compared to control cells  
(p < 0.05), ** significant difference compared to control cells (p < 0.001). 
(a) (b) 
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As observed in Figure 2a, the nitrite concentration was measured in the supernatants of the cultured 
cells at 12 and 24 h post-stimulation. No significant difference vs. control cells was found at 12 h  
(p > 0.05 in all cases). After 24 h, cells cultured in the presence of either 1 mM L-NAME or 10 µM, 
curcumin had significantly decreased NO production (p < 0.001) (Figure 2a). Furthermore, the 
combination of both agonists abrogated NO production in MG-63 cells after 24 h of incubation (Figure 2a). 
Figure 2. (a) Nitrite production by MG-63 cells at 12 and 24 h. Nitrite production was 
expressed as percentage of control (unstimulated cells). ** (p < 0.001), n.s. (not 
significant) vs. control cells in both cases. Bars represent mean values; error bars represent 
SEM. (b) Temporal changes in the expression of iNOS mRNA after curcumin (10 µM) 
exposure after 6, 12 and 24 h. Dots represent mean values; error bars represent SEM.  
** Significant difference compared to control cells (p < 0.001). 
(a) (b) 
2.2. iNOS/eNOS Gene Expression 
The results of the quantitative PCR analysis of MG-63 cells cultured in the presence of 10 µM 
curcumin are shown in Figure 2b. iNOS mRNA expression was significantly altered after 12 h of 
culture in the presence of 10 µM curcumin (p < 0.01). In contrast, the eNOS expression was not 
affected by incubation with curcumin (p > 0.05) (Figure 2b). 
2.3. Mineralization 
From days 7–15, MG-63 cells exhibited significant AR-S staining in the presence of OM  
(Figure 3a). With increasing culture time, AR-S staining in the cells of the control group increased 
gradually. However, from days 15–21, AR-S staining was decreased in the experimental groups 
(Figure 3a). AR-S staining was used to quantify mineralized nodules. Curcumin did not decrease the 
rate of mineralization in MG-63 cells (p > 0.05 vs. OM). In contrast, L-NAME significantly decreased 
the number of nodules (p < 0.05 vs. OM), while the combination of both agonists greatly decreased the 
rate of MG-63 cell mineralization (p < 0.001 vs. OM) (Figure 3b). 
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Figure 3. (a) Effect of curcumin (10 µM) and L-NAME (1 mM) on mineralized nodules in 
MG-63 cells. Cells were untreated or treated with osteogenic medium, osteogenic medium 
+ curcumin, osteogenic medium + LNAME or osteogenic medium + curcumin and  
L-NAME for 21 days, and, then, mineralization was determined by AR-S staining.  
(b) Results are expressed as percentage of control. The data are expressed as mean ± SEM 
of three determinants. n.s. (no significant difference compared to control cells),  
* significant difference compared to control cells (p < 0.05), ** significant difference 
compared to control cells (p < 0.001). 
2.4. COLI/OCN Gene Expression 
The results of the quantitative PCR assay of MG-63 cells cultured with either 10 µM curcumin or 
OM are shown in Figure 4. The rate of COLI mRNA expression remained constant and decreased from 
day 15 to day 21 of culture (p < 0.01). No significant differences were found in the rate of expression 
between control (OM) cells and curcumin-stimulated cells (p > 0.05) (Figure 4a). Similarly, the levels 
of OCN remained constant until day 15, when a significant (p < 0.01) increase was detected  
(Figure 4a). No significant differences were found between the rate of expression observed in control 
(OM) cells and curcumin-stimulated cells after 21 days of culture (Figure 4b). 
2.5. ALP Activity and Gene Expression 
Figure 5a shows the ALP activity in MG-63 cells in the presence of OM or OM + 10 µM curcumin 
after the number of days indicated. ALP activity increased constantly from day 7 with culture time. 
Statistically significant differences were observed thereafter (p < 0.001 vs. 0.5 days). Significant 
differences between the experimental conditions were found from day 9 after culture to the end of the 
experiment (p < 0.001). In all cases, cells cultured in the presence of 10 µM curcumin exhibited lower 
ALP activity than the OM group (Figure 5a). 
The results of the quantitative PCR assay of MG-63 cells cultured with either 10 µM curcumin or 
OM at the indicated times are shown in Figure 5b. Significant differences in ALP mRNA expression 
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were observed between cells cultured in the presence of OM or OM + 10 µM curcumin vs. 
unstimulated cells at 7, 15 and 21 days of culture (p < 0.05). No significant differences were found 
between OM and OM + 10 µM curcumin at any time point tested (p > 0.05) (Figure 5b).  
Figure 4. (a) Time course of alterations in COLI mRNA and OCN mRNA.  
(b) Concentration after the 7, 15 and 21 day of exposure to 10 µM curcumin + osteogenic 
medium or osteogenic medium alone. Total cellular RNA was extracted from MG-63 cells 
as described in Methods. COLI and OCN mRNA amount was determined by performing 
RT-PCR. Data represent the mean ± SEM for a minimum of three separate experiments.  
** Significant difference compared to day 15 cells (p < 0.01). Not significant differences 
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Figure 5. (a) The ALP activity of MG-63 cells at 0.5, 1, 1.5, 2, 3, 7, 9, 12, 15 and 21 post 
seeding in the presence of either osteogenic medium or osteogenic medium + curcumin  
10 µM. ** (p < 0.001 vs. day 0.5 in both conditions). Significant differences (p < 0.001) 
were found from day 9 of culture to the end of the experiment between the experimental 
conditions. (b) Time course of alterations in ALP mRNA concentration after the 3, 7, 15 
and 21 day of exposure to 10 µM curcumin + osteogenic medium, osteogenic medium or 
culture medium (unstimulated). Total cellular RNA was extracted from MG-63 cells as 
described in Methods. ALP mRNA amount was determined by performing RT-PCR. Data 
represent the mean ± SEM for a minimum of three separate experiments. * Significant 
difference compared to unstimulated cells (p < 0.05). Not significant differences were 








Curcumin is a natural polyphenol extracted from Curcuma longa. Curcumin exhibits potent 
antioxidant and anti-inflammatory activity, inhibiting the production of free radicals, promoting radical 
scavenging and suppressing the production and release of inflammatory mediators. These properties 
may facilitate the attenuation of tissue and cellular injury in the liver, heart, kidney, brain and bone, 
induced by oxidation or inflammation. Curcumin has a long history of use as a medicinal compound 
and is known to also have multiple anti-cancer properties. It also affects a broad range of cellular 
targets at the molecular level, including STAT3 [26], Wnt/β-catenin [27], NF-κB [28] and HER2 [1], 
and the proteasome [29]. Curcumin also induce apoptosis regulated by multiple signaling pathways, 
induce or accentuate apoptosis indirectly by sensitizing cells to chemotherapeutical drugs and some 
contrary studies show that curcumin is also able to inhibit apoptosis [30]. 
In the present study, we showed that the treatment of MG-63 cells with curcumin inhibited their 
proliferation. This result is consistent with previous studies performed in human [9] or rat [10] 
osteoblast and with others, indicating that curcumin inhibited the proliferation of several cell types, 
most likely due to an apoptosis-dependent mechanism [31]. This mechanism has not been completely 
elucidated, but it may be, at least in part, due to the ability of curcumin to suppress the activation of 
AP-1, a dimeric transcription factor consisting of a Fos-related protein and a Jun-related protein as 
recently described [32]. 
In recent years, the beneficial effect of NO in bone tissue has received particular attention. 
However, the mechanism underlying the protective effect of NO against bone damage has not been 
fully elucidated. The impact of NO on osteoblast metabolism is bi-directional. Under physiological 
conditions, NO derived from eNOS is an important local mediator and second messenger for systemic 
hormones, including calcitonin gene-related peptide, parathyroid hormone and sex steroids, 
particularly estrogen, which take part in the regulation of bone function [33]. However, excess local 
production of NO (as observed with the use of NO donors) induces cytotoxicity in osteoblastic  
cells [34]. Thus, a biphasic role has been attributed to NO in osteoblast activity. In vitro studies have 
shown that the small amount of NO produced constitutively by osteoblasts might act as an autocrine 
stimulator of osteoblast growth and differentiation, while high NO concentrations inhibit cellular 
proliferation without affecting differentiation. Recent evidence suggests that high NO concentrations 
may exert at least a pro-apoptotic effect on osteoblasts and that this is mediated in part by cGMP [35]. 
While some investigators have shown that slow-release NO donors stimulate osteoblast growth and 
differentiation in vitro [36], other researchers report that NO donors and NOS inhibitors have little 
effect on osteoblast growth or differentiation, except at high concentrations, where inhibitory effects 
were observed [37]. 
Thus, the observed cellular response appears to depend, in some manner, on the NO concentration. 
In the present study, the cellular nitric oxide level was measured using the Griess reaction. The data 
demonstrate that NO secretion by curcumin-treated cells is significantly lower than unstimulated cells. 
To further examine the role of endogenous NO formation, we used a pharmacological approach to 
interfere with this pathway at two levels: (1) L-NAME, which specifically inhibits NOS activity and 
blocks signal transduction from NOS to NO; and (2) curcumin, which downregulates iNOS expression. 
As L-NAME has an effect on arginine metabolism, it could in fact affect protein synthesis and, 
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consequently, the mineralization process in MG-63 cells. In this sense, it has been described that  
L-NAME weakly affects arginine availability and arginine transport activity in MG-63 cells [38].  
Together, curcumin and L-NAME successfully abolished the NO levels in MG-63 cells. NO plays a 
fundamental role in the differentiation of osteoblasts, and it acts as an important second messenger in 
the signaling process that leads to extracellular matrix maturation, activating soluble guanylyl cyclase 
to produce cGMP, which in turn stimulates protein kinase G [39].  
Osteoblast differentiation comprises three distinct processes: proliferation, maturation of the 
extracellular matrix and mineralization. During their developmental sequence, osteoblasts express 
genes associated with differentiation. ALP is important in the extracellular matrix maturation period, 
during which it forms calcified nodules. We observed that curcumin can modulate the differentiation 
of MG-63 cells, which was also indicated by differentiation markers ALP, OCN and COLI and the 
mineralization study (in combination with L-NAME). We observed changes in the early stages, with 
increased ALP expression in curcumin-stimulated cells at seven days post-culture. However, there was 
a significant decrease in the late stages of osteoblast differentiation at day 21, evidenced by the 
decelerating accumulation of calcium in osteoblasts. We failed to detect changes in the expression of 
OCN and COLI in the experimental groups, which might indicate that curcumin does not affect their 
mRNA expression, although it has been proposed that NO might enhance OCN gene expression 
through the cAMP response element activated by cGMP [40]. However, lower ALP activity was 
detected in curcumin-stimulated MG-63 cells, confirming an effect on osteoblast differentiation. ALP 
is a biomarker used to evaluate bone metabolism; staining methods are also commonly used to 
visualize bone nodule formation. The mineralization study revealed significant differences in the 
number of calcified bodies in curcumin-treated cells that significantly decreased when curcumin was 
combined with the NOS inhibitor L-NAME. This in vitro evidence suggests that NO may have a role 
in the mechanism leading to MG-63 cell differentiation to osteoblasts as proposed by others [19].  
Not surprisingly, the osteogenic differentiation marker levels in the curcumin-treated groups were 
significantly lower than in the unstimulated cultures. These results suggest that NO itself or cGMP 
(latter produced by NO signaling) might promote osteoblastic metabolism and that its inhibition affects 
it. Additionally, it has recently been proposed that curcumin and curcumin analogs play a positive role 
in the differentiation of mouse osteoblasts by stimulating Smad signaling and suppressing NF-κB 
activation [41,42]. The inhibition of NF-κB signaling and the subsequent expression of iNOS and other 
molecules has been widely described in several cell lines and culture conditions [24]. 
As a limitation of our study, we did not address the signaling pathways mediated by NO in MG-63 
cells or whether the inhibition of its expression is sufficient to trigger the inhibition of the pathway’s 
downstream elements, which may affect the process of osteogenesis. Further studies are needed to 
clarify these issues. 
3. Experimental Section 
3.1. Tissue Culture 
A human osteoblast-like cell line, MG-63, was used as the osteoblasts in this study. The cells were 
maintained in a medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
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with 10% (v/v) heat-inactivated fetal calf serum (Invitrogen Gibco Cell Culture Products, Carlsbad, CA, 
USA), 2 mM glutamine, 100 units/mL penicillin G, 100 µg/mL streptomycin sulfate and 2.5 μg/mL 
amphotericin B (Sigma, St. Louis, MO, USA). Cultures were kept at 37 °C in a humidified atmosphere 
of 95% air and 5% CO2. Upon reaching 70% confluence, cells were detached from the culture flask 
with a solution of 0.05% trypsin (Sigma, St. Louis, MO, USA) and 0.02% ethylenediaminetetraacetic 
acid (EDTA) (Sigma, St. Louis, MO, USA). 
3.2. Cell Proliferation 
Cell proliferation was determined by the MTT method. Osteoblasts were seeded at 1 × 104 cells/mL 
per well in a 96-well plate without FBS and cultured at 37 °C for 24 h. Subsequently, the medium was 
replaced with DMEM containing either curcumin (dissolved in ethanol) at the indicated doses (10, 20 
or 30 µM), 1 mM L-NG-nitroarginine methyl ester (L-NAME) or 0.2 mM sodium nitroprusside (SNP) 
(both dissolved in DMEM) (all from Sigma, St. Louis, MO, USA). At the end of the treatments (24 h), 
the medium was replaced with DMEM containing 0.5 mg/mL MTT (Sigma) and incubated for 4 h. 
Cellular reduction of the MTT tetrazolium ring resulted in the formation of a dark-purple water-insoluble 
deposit of formazan crystals. After incubation, the medium was aspirated, and DMSO was added to 
dissolve the formazan crystals. Absorbance was measured at 570 nm with a spectrophotometer. 
3.3. Determination of Nitrite/Nitrate (NOx) Concentrations 
Nitrite production was measured using the Griess reaction. After a 10 min incubation at 37 °C in the 
dark, absorbance was measured at 540 nm. A blank was prepared in the absence of cells, and its 
absorbance was subtracted from the sample absorbance. Sodium nitrite was used as a standard to build 
a calibration curve. Nitrite concentration was expressed as a percentage of the unstimulated cell  
nitrite concentration. 
3.4. RNA Purification 
RNA was purified from cells (5 × 106) used in various experiments. Total RNA was isolated using 
the TRI REAGENT kit according to the manufacturer’s instructions (Sigma, St. Louis, MO, USA). 
Briefly, 1 mL of TRI REAGENT was added directly to the culture dish. The cell lysates were 
transferred by pipetting to an Eppendorf tube and incubated for 5 min at room temperature, and 0.2 mL 
of chloroform per 1 mL of TRI REAGENT was added to the tubes. The tubes were vortexed for an 
additional 15 min and incubated for 15 min at room temperature (RT). The resulting mixture was 
centrifuged at 12,000g for 15 min. The aqueous phase was transferred to a fresh tube, and 0.5 mL of 
isopropanol was added. Samples were incubated for 10 min at RT and centrifuged at 12,000g for  
15 min. Finally, the supernatant was removed, and the RNA pellet was washed twice with 1 mL 75% 
ethanol and once with 1 mL of 100% ethanol.  
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3.5. Quantitative Reverse Transcription-Polymerase Chain Reaction (RT-PCR) for iNOS, eNOS,  
Type I Collagen (COLI), Alkaline Phosphatase, Osteocalcin (OCN) and β-actin Genes 
Total RNA (5 µg) was used as a template to synthesize cDNA using a Moloney Murine Leukemia 
Virus First Strand cDNA Synthesis Kit (Gene Choice, Frederick, MD, USA). The reaction buffer 
contained random hexamer primers and deoxynucleotide triphosphates (dNTPs). Aliquots of the 
cDNA product were used as the template for quantitative real-time polymerase chain reaction  
(RT-PCR) analysis, which was performed using an Applied Biosystems 7300 Real-Time PCR System 
(Foster City, CA, USA) and SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan). The relative  
gene expression levels were normalized to the amount of β-actin mRNA. The primer sequences  
were as follows: human b-actin, 5'-CCACACCTTCTACAATGAGC-3' (upstream) and 5'-CTCGTAG 
ATGGGCACAGTGT-3' (downstream); human type I collagen alpha I, 5'-AAGATGTGCCACTCTG 
ACTG-3' (upstream) and 5'-ATAGGTGATGTTCTGGGAGG-3' (downstream); human alkaline 
phosphatase, 5'-CATCTGGAACCGCACGGAAC-3' (upstream) and 5'-GCCTGGTAGTTGTTGTGA 
GC-3' (downstream); human osteocalcin, 5'-CTCACACTCCTCGCCCTATT-3' (upstream) and  
5'-CAACTCGCACAGTCCGGAT-3' (downstream); human eNOS, 5'-CCTGGAGAATGAGCAGA 
AGG-3' (upstream) and 5'-GATGCTGTTGAAGCGGATCT-3' (downstream); and human iNOS,  
5'-TCTTCGAAATCCCACCTGAC-3' (upstream) and 5'-TTTTCCAGGCCTCTACCTGA-3' 
(downstream). 
3.6. Alkaline Phosphatase (ALP) Activity 
For the ALP activity assay, the cells were incubated with 4 mg/mL of a ρ-nitrophenyl phosphate 
solution (Sigma, St. Louis, MO, USA) at 37 °C for 30 min. ρ-Nitrophenol (PNP) production in the 
presence of ALP was measured by monitoring the solution absorbance at 405 nm using a 
spectrophotometer. The protein content of the extracts was measured using the Bio-Rad DC protein 
assay, and ALP activity was expressed as µmol/min/mg protein. 
3.7. Mineralization 
Alizarin red-S (AR-S) staining is a common histochemical technique used to detect calcium 
deposits in mineralized tissues and cultures, and positive AR-S staining for calcium has been shown to 
represent calcium phosphate and osteoblast culture mineralization. Control group cells were incubated 
in osteogenic medium (OM) containing 10% FBS, 50 g/mL ascorbic acid and 10 mM  
2-glycerophosphate. The experimental groups were incubated with 10 µM curcumin, 1 mM L-NAME 
or both. After incubation for 21 days, cells were collected and stained with alizarin red. The cells were 
washed with PBS and fixed in 70% ethanol for 1 h at 4 °C. After additional washing in PBS, they were 
incubated in 0.4% alizarin red-S in water for 10 min at room temperature, followed by a final 
incubation in PBS for 15 min. The stained cells were photographed and then subjected to a quantitative 
destaining procedure using 10% (w/v) cetylpyridinium chloride in 10 mmol L−1 sodium phosphate  
(pH 7.0) for 30 min at room temperature. Absorbance was measured at 562 nm on a spectrophotometer, 
and the results were expressed as a percentage of the control (unstimulated) cell absorbance. 
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3.8. Data Analysis 
The results were expressed as the means ± SEM. Statistical analyses were performed with ANOVA 
and Fisher’s exact test, when appropriate. The P value cutoff for statistical significance was defined as 
p < 0.05. For the single agonist experiment, the differences between group means were evaluated by 
Student’s t test (SPSS statistical package, version 19.0, IBM-SPSS: Chicago, IL, USA, 2010). 
Differences were considered statistically significant when p < 0.05.  
4. Conclusions 
In conclusion, curcumin exposure of MG-63 cells modulates osteoblastic differentiation by a 
mechanism partially related to the inhibition of NO production.  
The results described in this report can be summarized as follows. (1) The treatment of MG-63 cells 
with curcumin abrogated iNOS expression and decreased NO levels. (2) Treatment with both curcumin 
and L-NAME decreased NO levels, inhibiting cell proliferation. This effect was prevented by the NO 
donor SNP, thereby indicating a role for NO as a regulatory factor in MG-63 proliferation. (3) Under 
osteogenic conditions, the incubation of MG-63 cells with both curcumin and L-NAME decreased the 
level of mineralization, indicating that NO plays a role in the osteoblastic profile of MG-63 cells. 
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